Canada Life
BMY.RT

Canada Life’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Canada Life’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-177,067
Closed -$123K – 2641
2020
Q4 		$123K Hold
177,067
– – ﹤0.01% 2074
2020
Q3 		$399K Hold
177,067
– – ﹤0.01% 1732
2020
Q2 		$633K Hold
177,067
– – ﹤0.01% 1617
2020
Q1 		$674K Hold
177,067
– – ﹤0.01% 1489
2019
Q4 		$528K Buy
+177,067
New +$460K ﹤0.01% 1696

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Canada Life's BMY.RT Position: Q1 2021 in Review

Canada Life sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 177,067 shares — an estimated $123K sold.

Canada Life first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $674K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Canada Life reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Canada Life sold 177,067 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $123K.
  • Canada Life first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Canada Life's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $674K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Canada Life's 13F filing for Q1 2021, filed 17 May 2021.